ClinicalTrials.govpublic full text
Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)
gastric cancer (gc), locally advanced gastric cancer, neoadjuvant immunotherapy, artificial intelligence, deep learning, pathological complete response, pd-1 inhibitors, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 839882
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.